Kacholia-backed Fineotex Chemical Allots Shares, Boosts Capital

CHEMICALS
Whalesbook Logo
AuthorAarav Shah|Published at:
Kacholia-backed Fineotex Chemical Allots Shares, Boosts Capital
Overview

Fineotex Chemical Limited has approved the allotment of 50 lakh equity shares following warrant conversions, raising ₹14.53 crore. The company also forfeited over 23 lakh warrants. This boosts paid-up capital and maintains a promoter holding of 61.87%. While quarterly results showed strong growth, FY25 financials saw a decline. Notably, ace investor Ashish Kacholia holds a significant stake.

Fineotex Chemical Limited (FCL) finalized the allotment of 50,00,000 equity shares, a move stemming from the conversion of 5,00,000 warrants by Intuitive Alpha Investment Fund PCC. This transaction, which brought in the remaining ₹14.53 crore of the exercise price, injects fresh capital and boosts the company's paid-up share capital to ₹116.45 crore.

Shareholder Structure Shift

The allotment reshapes the company's shareholding. Promoters now hold 61.87 percent, while non-promoter investors command 38.13 percent of the equity. In a separate development, Fineotex confirmed the forfeiture of 2,315,049 warrants. These lapsed as holders failed to exercise their conversion rights within the stipulated 18-month period, leading to the forfeiture of approximately ₹22.42 crore by the company, in line with SEBI regulations.

Investor Confidence and Market Performance

The stock, currently trading with a market capitalization exceeding ₹2,700 crore, has demonstrated strong long-term performance. It has surged over 250 percent in the last five years and is up 20 percent from its 52-week low of ₹19.21. This performance aligns with investor confidence, including that of noted investor Ashish Kacholia, who holds a 2.59 percent stake as of September 2025. The company reports robust return metrics with an ROE of 18 percent and ROCE of 24 percent.

Financial Performance Snapshot

Fineotex Chemical posted a strong sequential quarterly performance. Consolidated total income rose 15 percent quarter-on-quarter to ₹146.22 crore. Operational efficiency improvements were reflected in an 18 percent increase in EBITDA to ₹25.20 crore and a 24 percent jump in net profit to ₹25.03 crore. This quarter also saw the commissioning of a new ₹60 crore manufacturing facility. However, the full fiscal year 2025 results presented a less optimistic picture, with net sales declining to ₹533 crore from ₹569 crore in FY24, and net profit falling to ₹109 crore from ₹121 crore.

The company continues its strategy of expanding capacity and market reach for its specialty chemicals across various industries including textiles, home care, and oil & gas.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.